MC 510125
Alternative Names: MF-BA1768-aLatest Information Update: 04 Oct 2004
At a glance
- Originator Essential Therapeutics [CEASED]
- Class Antibacterials
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 04 Oct 2004 Discontinued - Preclinical for Bacterial infections in USA (unspecified route)
- 11 Jan 2002 New profile
- 11 Jan 2002 Preclinical development for Bacterial infections in USA (Unknown route)